The University of Chicago Header Logo

Connection

Mark Talamonti to Humans

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Humans.
Mark Talamonti
Connection Strength
1.293
Humans
  1. Endovascular management of portal vein obstruction in hepatobiliary cancer patients. J Surg Oncol. 2022 Mar; 125(3):392-398.
    View in: PubMed
    Score: 0.027
  2. Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e770-e772.
    View in: PubMed
    Score: 0.025
  3. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature. Expert Opin Biol Ther. 2020 06; 20(6):665-672.
    View in: PubMed
    Score: 0.024
  4. Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience. Expert Opin Biol Ther. 2020 01; 20(1):95-104.
    View in: PubMed
    Score: 0.024
  5. Postoperative venous thromboembolism and mortality in patients with pancreatic surgery. J Surg Oncol. 2019 Sep; 120(3):494-500.
    View in: PubMed
    Score: 0.023
  6. Pancreatic cancer thromboembolic outcomes: rate of thrombosis after adenocarcinoma and non-adenocarcinoma pancreatic cancer surgery. Int Angiol. 2019 Jun; 38(3):194-200.
    View in: PubMed
    Score: 0.023
  7. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature. Dermatol Ther. 2019 05; 32(3):e12899.
    View in: PubMed
    Score: 0.023
  8. Impact, Insight, and Innovation: Our Legacy of Learning. J Am Coll Surg. 2019 07; 229(1):1-6.
    View in: PubMed
    Score: 0.023
  9. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study. J Eur Acad Dermatol Venereol. 2018 Oct; 32(10):1737-1744.
    View in: PubMed
    Score: 0.022
  10. Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients. Br J Dermatol. 2017 Aug; 177(2):489-496.
    View in: PubMed
    Score: 0.020
  11. Brodalumab for the treatment of psoriasis. Expert Rev Clin Immunol. 2016 Dec; 12(12):1255-1271.
    View in: PubMed
    Score: 0.019
  12. HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis. Mol Diagn Ther. 2016 06; 20(3):227-30.
    View in: PubMed
    Score: 0.019
  13. Management Controversies and Treatment Strategies for Borderline Resectable Pancreatic Cancer. Cancer Treat Res. 2016; 168:59-75.
    View in: PubMed
    Score: 0.018
  14. Screening Strategies for Pancreatic Cancer in High-Risk Patients: Opportunities to Make a Real Impact But Many Questions and Challenges Still Ahead. JAMA Surg. 2015 Jun; 150(6):518-9.
    View in: PubMed
    Score: 0.018
  15. Interval asymptomatic infected postpancreatic resection fluid collections managed with endoscopic ultrasound-guided drainage. Am Surg. 2015 Apr; 81(4):E146-7.
    View in: PubMed
    Score: 0.017
  16. Percutaneous transhepatic placement of a stent-graft to treat a delayed mesoportal hemorrhage after pancreaticoduodenectomy. World J Surg Oncol. 2014 Oct 15; 12:315.
    View in: PubMed
    Score: 0.017
  17. Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy. J Surg Oncol. 2014 Sep; 110(4):400-6.
    View in: PubMed
    Score: 0.016
  18. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2013 Oct; 154(4):785-91; discussion 791-3.
    View in: PubMed
    Score: 0.016
  19. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br J Dermatol. 2013 Aug; 169(2):458-63.
    View in: PubMed
    Score: 0.015
  20. Defining quality for distal pancreatectomy: does the laparoscopic approach protect patients from poor quality outcomes? J Gastrointest Surg. 2013 Feb; 17(2):273-80.
    View in: PubMed
    Score: 0.015
  21. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol. 2012 Sep 01; 106(3):339-45.
    View in: PubMed
    Score: 0.014
  22. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology. J Surg Oncol. 2012 Sep 01; 106(3):332-8.
    View in: PubMed
    Score: 0.014
  23. Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study. Arch Dermatol Res. 2022 Aug; 314(6):593-603.
    View in: PubMed
    Score: 0.013
  24. Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer. Int J Radiat Oncol Biol Phys. 2011 Jun 01; 80(2):476-82.
    View in: PubMed
    Score: 0.013
  25. Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. Dermatology. 2011; 222(3):250-5.
    View in: PubMed
    Score: 0.013
  26. Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy. Am J Surg. 2011 Mar; 201(3):295-9; discussion 299-300.
    View in: PubMed
    Score: 0.013
  27. The effects of bevacizumab on postoperative complications in patients undergoing colorectal and pancreatic cancer resection. J Surg Oncol. 2010 Oct 01; 102(5):539-42.
    View in: PubMed
    Score: 0.013
  28. Quality improvement for pancreatic cancer care: is regionalization a feasible and effective mechanism? Surg Oncol Clin N Am. 2010 Apr; 19(2):371-90.
    View in: PubMed
    Score: 0.012
  29. Neoadjuvant therapy for pancreatic cancer: a current review. J Surg Oncol. 2010 Mar 15; 101(4):315-20.
    View in: PubMed
    Score: 0.012
  30. A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy. Surgery. 2009 Oct; 146(4):635-43; discussion 643-5.
    View in: PubMed
    Score: 0.012
  31. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
    View in: PubMed
    Score: 0.011
  32. Endoscopic ultrasound for gastric cancer: a technique for preoperative risk stratification in need of further refinements. Ann Surg Oncol. 2007 Dec; 14(12):3293-4.
    View in: PubMed
    Score: 0.010
  33. Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg. 2007 Nov; 194(5):588-93.
    View in: PubMed
    Score: 0.010
  34. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007 Oct; 142(4):529-34; discussion 534-7.
    View in: PubMed
    Score: 0.010
  35. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer. 2007 Sep 15; 110(6):1227-34.
    View in: PubMed
    Score: 0.010
  36. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer. 2007 Aug 15; 110(4):738-44.
    View in: PubMed
    Score: 0.010
  37. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007 Oct; 205(4):558-63.
    View in: PubMed
    Score: 0.010
  38. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007 Aug; 246(2):173-80.
    View in: PubMed
    Score: 0.010
  39. Guidelines for the surgical management of pancreatic adenocarcinoma. Semin Oncol. 2007 Aug; 34(4):311-20.
    View in: PubMed
    Score: 0.010
  40. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg. 2007 Mar; 193(3):389-93; discussion 393-4.
    View in: PubMed
    Score: 0.010
  41. Borderline resectable pancreatic cancer: a new classification for an old challenge. Ann Surg Oncol. 2006 Aug; 13(8):1019-20.
    View in: PubMed
    Score: 0.009
  42. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience. Am J Surg. 2006 Mar; 191(3):437-41.
    View in: PubMed
    Score: 0.009
  43. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol. 2006 Feb; 13(2):150-8.
    View in: PubMed
    Score: 0.009
  44. Surgical management of pancreatic cancer. Semin Radiat Oncol. 2005 Oct; 15(4):218-25.
    View in: PubMed
    Score: 0.009
  45. Preoperative evaluation of pancreatic cystic lesions: cost-benefit analysis and proposed management algorithm. Surgery. 2005 Oct; 138(4):672-9; discussion 679-80.
    View in: PubMed
    Score: 0.009
  46. Adenocarcinoma arising in rectal duplication cyst: case report and review of the literature. Am Surg. 2004 Nov; 70(11):1007-9.
    View in: PubMed
    Score: 0.008
  47. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
    View in: PubMed
    Score: 0.008
  48. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
    View in: PubMed
    Score: 0.008
  49. Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. JAMA Oncol. 2023 09 01; 9(9):1245-1254.
    View in: PubMed
    Score: 0.008
  50. Residents perform better technically, have less stress and workload, and prefer robotic to laparoscopic technique during inanimate simulation. Surg Endosc. 2023 09; 37(9):7230-7237.
    View in: PubMed
    Score: 0.008
  51. Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort. Thromb Res. 2023 09; 229:69-72.
    View in: PubMed
    Score: 0.008
  52. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. JAMA. 2023 05 09; 329(18):1579-1588.
    View in: PubMed
    Score: 0.008
  53. A core set of quality performance indicators for HPB procedures: a global consensus for hepatectomy, pancreatectomy, and complex biliary surgery. HPB (Oxford). 2023 08; 25(8):924-932.
    View in: PubMed
    Score: 0.008
  54. Number of Hepatic Resections and Association with Complication after Metastatic Neuroendocrine Tumor Debulking: An American College of Surgeons NSQIP Database Study. J Am Coll Surg. 2023 07 01; 237(1):157-168.
    View in: PubMed
    Score: 0.008
  55. Does minimally invasive surgery have a different impact on recurrence and overall survival in patients with pancreatic head versus body/tail cancer? J Surg Oncol. 2023 Jul; 128(1):23-32.
    View in: PubMed
    Score: 0.008
  56. Robotic Pancreaticoduodenectomy for Intraductal Papilary Mucinous Neoplasm in a Patient post Roux-en-Y Gastric Bypass. Obes Surg. 2023 04; 33(4):1309-1310.
    View in: PubMed
    Score: 0.007
  57. Risk factors and outcomes in patients undergoing minimally invasive hepatectomy with unplanned conversion: a contemporary NSQIP analysis. HPB (Oxford). 2023 05; 25(5):577-588.
    View in: PubMed
    Score: 0.007
  58. Staging and surgical management of pancreatic and biliary cancer and inflammation. Radiol Clin North Am. 2002 Dec; 40(6):1397-410, viii.
    View in: PubMed
    Score: 0.007
  59. Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the minimally invasive approach. J Surg Oncol. 2023 Mar; 127(3):413-425.
    View in: PubMed
    Score: 0.007
  60. Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Arch Surg. 2002 May; 137(5):564-70; discussion 570-1.
    View in: PubMed
    Score: 0.007
  61. Bile leak incidence, risk factors and associated outcomes in patients undergoing hepatectomy: a contemporary NSQIP propensity matched analysis. Surg Endosc. 2022 08; 36(8):5710-5723.
    View in: PubMed
    Score: 0.007
  62. Pathologic quiz case: a cystic pancreatic mass discovered in a patient with ileocecal carcinoid. Arch Pathol Lab Med. 2002 Feb; 126(2):229-30.
    View in: PubMed
    Score: 0.007
  63. Pancreaticoduodenectomy in a patient with ampullary carcinoma and situs inversus. Surgery. 2001 Sep; 130(3):521-4.
    View in: PubMed
    Score: 0.007
  64. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study. J Eur Acad Dermatol Venereol. 2021 Apr; 35(4):958-964.
    View in: PubMed
    Score: 0.006
  65. Clinical features of primary and metastatic hepatic malignancies. Cancer Treat Res. 2001; 109:1-14.
    View in: PubMed
    Score: 0.006
  66. Screening for colorectal cancer: developing a preventive healthcare program utilizing nurse endoscopists. Gastroenterol Nurs. 2001 Jan-Feb; 24(1):12-9.
    View in: PubMed
    Score: 0.006
  67. Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank. Int J Cancer. 2021 04 01; 148(7):1658-1664.
    View in: PubMed
    Score: 0.006
  68. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol. 2000 Oct 01; 18(19):3384-9.
    View in: PubMed
    Score: 0.006
  69. Robotic pancreaticoduodenectomy decreases the risk of clinically relevant post-operative pancreatic fistula: a propensity score matched NSQIP analysis. HPB (Oxford). 2021 03; 23(3):367-378.
    View in: PubMed
    Score: 0.006
  70. Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching. J Surg Oncol. 2020 Aug; 122(2):183-194.
    View in: PubMed
    Score: 0.006
  71. Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):911-915.
    View in: PubMed
    Score: 0.006
  72. The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection. Ann Surg. 2020 01; 271(1):1-14.
    View in: PubMed
    Score: 0.006
  73. Variation in Hospital Utilization of Minimally Invasive Distal Pancreatectomy for Localized Pancreatic Neoplasms. J Gastrointest Surg. 2020 12; 24(12):2780-2788.
    View in: PubMed
    Score: 0.006
  74. Response to IL-17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL-17A gene: results from a multicentre study of four European psoriasis cohorts. J Eur Acad Dermatol Venereol. 2020 Jan; 34(1):112-118.
    View in: PubMed
    Score: 0.006
  75. NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer. Anticancer Res. 1999 Jul-Aug; 19(4A):2411-4.
    View in: PubMed
    Score: 0.006
  76. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. PLoS One. 2018; 13(8):e0202272.
    View in: PubMed
    Score: 0.005
  77. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
    View in: PubMed
    Score: 0.005
  78. Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score). Ann Surg. 2018 04; 267(4):716-720.
    View in: PubMed
    Score: 0.005
  79. Minimally invasive pancreatoduodenectomy: is the incidence of clinically relevant postoperative pancreatic fistula comparable to that after open pancreatoduodenectomy? Surgery. 2018 03; 163(3):587-593.
    View in: PubMed
    Score: 0.005
  80. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery. 2018 03; 163(3):582-586.
    View in: PubMed
    Score: 0.005
  81. Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Surgery. 2018 05; 163(5):1047-1052.
    View in: PubMed
    Score: 0.005
  82. Local-regional therapy for metastatic liver tumors. Cancer Treat Res. 1998; 98:172-99.
    View in: PubMed
    Score: 0.005
  83. The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2018 02; 20(2):140-146.
    View in: PubMed
    Score: 0.005
  84. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
    View in: PubMed
    Score: 0.005
  85. Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2017 Nov; 14(11):1429-1437.
    View in: PubMed
    Score: 0.005
  86. Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery. 2017 11; 162(5):1032-1039.
    View in: PubMed
    Score: 0.005
  87. Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy. J Gastrointest Surg. 2017 Oct; 21(10):1620-1625.
    View in: PubMed
    Score: 0.005
  88. Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience. Ann Surg Oncol. 2017 Sep; 24(9):2770-2776.
    View in: PubMed
    Score: 0.005
  89. Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy. J Am Coll Surg. 2017 May; 224(5):816-825.
    View in: PubMed
    Score: 0.005
  90. Rectus abdominis atrophy after ventral abdominal incisions: midline versus chevron. Hernia. 2017 08; 21(4):619-622.
    View in: PubMed
    Score: 0.005
  91. Minimally invasive pancreatic resections: cost and value perspectives. HPB (Oxford). 2017 03; 19(3):225-233.
    View in: PubMed
    Score: 0.005
  92. Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy. Am J Surg. 2017 Mar; 213(3):512-515.
    View in: PubMed
    Score: 0.005
  93. Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. Am J Surg. 2017 Mar; 213(3):521-525.
    View in: PubMed
    Score: 0.005
  94. Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis. J Dermatolog Treat. 2017 Jun; 28(4):299-303.
    View in: PubMed
    Score: 0.005
  95. A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy. Ann Surg. 2016 Oct; 264(4):640-9.
    View in: PubMed
    Score: 0.005
  96. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma. Surgery. 2016 12; 160(6):1466-1476.
    View in: PubMed
    Score: 0.005
  97. Management of ductal carcinoma in situ. Semin Surg Oncol. 1996 Sep-Oct; 12(5):300-13.
    View in: PubMed
    Score: 0.005
  98. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016 08 17; 151(8):e161137.
    View in: PubMed
    Score: 0.005
  99. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24.
    View in: PubMed
    Score: 0.005
  100. A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. J Gastrointest Surg. 2016 Feb; 20(2):284-92.
    View in: PubMed
    Score: 0.005
  101. The Learning Curve Is Surmountable: In Reply to Fong and colleagues. J Am Coll Surg. 2016 Feb; 222(2):210-1.
    View in: PubMed
    Score: 0.005
  102. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol. 2016 06; 23(6):1956-62.
    View in: PubMed
    Score: 0.005
  103. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015 Oct; 47(10):1168-78.
    View in: PubMed
    Score: 0.004
  104. Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):175-84.
    View in: PubMed
    Score: 0.004
  105. Educating surgeons may allow for reduced intraoperative costs for inguinal herniorrhaphy. J Am Coll Surg. 2015 Jun; 220(6):1107-12.
    View in: PubMed
    Score: 0.004
  106. Pancreatic cancer and FOLFIRINOX: a new era and new questions. Cancer Med. 2015 Jun; 4(6):853-63.
    View in: PubMed
    Score: 0.004
  107. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Surg Endosc. 2015 Dec; 29(12):3528-34.
    View in: PubMed
    Score: 0.004
  108. Educating surgeons on intraoperative disposable supply costs during laparoscopic cholecystectomy: a regional health system's experience. Am J Surg. 2015 Mar; 209(3):488-92.
    View in: PubMed
    Score: 0.004
  109. The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes. Am J Surg. 2015 Mar; 209(3):557-63.
    View in: PubMed
    Score: 0.004
  110. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015 Jul; 22(7):2209-17.
    View in: PubMed
    Score: 0.004
  111. Cystic neoplasms of the pancreas. J Am Coll Surg. 1994 Dec; 179(6):747-57.
    View in: PubMed
    Score: 0.004
  112. CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. Am J Clin Oncol. 2014 Dec; 37(6):550-4.
    View in: PubMed
    Score: 0.004
  113. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
    View in: PubMed
    Score: 0.004
  114. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg. 2015 Jan; 19(1):117-23; discussion 123.
    View in: PubMed
    Score: 0.004
  115. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg. 2014 Aug; 260(2):372-7.
    View in: PubMed
    Score: 0.004
  116. Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients. Surg Endosc. 2014 Oct; 28(10):2803-7.
    View in: PubMed
    Score: 0.004
  117. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014 May; 21(5):1520-9.
    View in: PubMed
    Score: 0.004
  118. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993 Nov; 177(5):481-7.
    View in: PubMed
    Score: 0.004
  119. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest. 1993 Jan; 91(1):53-60.
    View in: PubMed
    Score: 0.004
  120. Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. J Gastrointest Surg. 2013 Jan; 17(1):94-100; discussion p. 100-1.
    View in: PubMed
    Score: 0.004
  121. Laparoscopic ischemic conditioning of the stomach prior to esophagectomy. Dis Esophagus. 2013 Jul; 26(5):479-86.
    View in: PubMed
    Score: 0.004
  122. Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study. Clin Dev Immunol. 2012; 2012:823854.
    View in: PubMed
    Score: 0.004
  123. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut. 2012 Oct; 61(10):1454-64.
    View in: PubMed
    Score: 0.003
  124. Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292). Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e607-13.
    View in: PubMed
    Score: 0.003
  125. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011 Apr; 253(4):779-85.
    View in: PubMed
    Score: 0.003
  126. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):189-98.
    View in: PubMed
    Score: 0.003
  127. The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab. Dermatology. 2010; 221 Suppl 1:43-7.
    View in: PubMed
    Score: 0.003
  128. Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg. 1990 Aug; 125(8):972-6; discussion 976-7.
    View in: PubMed
    Score: 0.003
  129. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med. 2010 Jul 13; 7(7):e1000307.
    View in: PubMed
    Score: 0.003
  130. Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma. J Surg Oncol. 2010 Jun 01; 101(7):587-92.
    View in: PubMed
    Score: 0.003
  131. Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg. 2010 Apr; 251(4):708-16.
    View in: PubMed
    Score: 0.003
  132. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 2010 Apr 01; 116(7):1674-80.
    View in: PubMed
    Score: 0.003
  133. Laparoscopic distal pancreatectomy using radiofrequency energy. Am J Surg. 2010 Mar; 199(3):401-4; discussion 404.
    View in: PubMed
    Score: 0.003
  134. Mucinous nonneoplastic cyst of the pancreas: apomucin phenotype distinguishes this entity from intraductal papillary mucinous neoplasm. Hum Pathol. 2010 Apr; 41(4):513-21.
    View in: PubMed
    Score: 0.003
  135. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg. 2009 Sep; 13(9):1692-8.
    View in: PubMed
    Score: 0.003
  136. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst. 2009 Jun 16; 101(12):848-59.
    View in: PubMed
    Score: 0.003
  137. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer. 2009 May 01; 115(9):1849-58.
    View in: PubMed
    Score: 0.003
  138. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009 Jul; 16(7):1727-33.
    View in: PubMed
    Score: 0.003
  139. Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers. Dermatology. 2009; 219(1):48-53.
    View in: PubMed
    Score: 0.003
  140. Methylation profile of circulating plasma DNA in patients with pancreatic cancer. J Surg Oncol. 2009 Feb 01; 99(2):119-22.
    View in: PubMed
    Score: 0.003
  141. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res. 2008 Oct 15; 14(20):6525-30.
    View in: PubMed
    Score: 0.003
  142. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 2008 Dec; 12(12):2078-86.
    View in: PubMed
    Score: 0.003
  143. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst. 2008 Sep 17; 100(18):1310-7.
    View in: PubMed
    Score: 0.003
  144. Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg. 2008 Sep; 248(3):438-46.
    View in: PubMed
    Score: 0.003
  145. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg. 2008 Jul; 143(7):671-8; discussion 678.
    View in: PubMed
    Score: 0.003
  146. Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer. J Am Coll Surg. 2008 Oct; 207(4):510-9.
    View in: PubMed
    Score: 0.003
  147. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008 Oct 01; 26(28):4626-33.
    View in: PubMed
    Score: 0.003
  148. Clear cell carcinoma of the pancreas: histopathologic features and a unique biomarker: hepatocyte nuclear factor-1beta. Mod Pathol. 2008 Sep; 21(9):1075-83.
    View in: PubMed
    Score: 0.003
  149. Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol. 2008 Jun 01; 97(7):578-82.
    View in: PubMed
    Score: 0.003
  150. The oblique rectus abdominal myocutaneous flap for complex pelvic wound reconstruction. Dis Colon Rectum. 2008 Aug; 51(8):1237-41.
    View in: PubMed
    Score: 0.003
  151. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008 Jul; 196(1):135-8.
    View in: PubMed
    Score: 0.003
  152. Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States. Ann Surg Oncol. 2008 Jul; 15(7):1948-58.
    View in: PubMed
    Score: 0.003
  153. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008 Jun; 15(6):1566-76.
    View in: PubMed
    Score: 0.003
  154. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology. 2008 May; 247(2):507-15.
    View in: PubMed
    Score: 0.003
  155. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008 Mar; 247(3):490-500.
    View in: PubMed
    Score: 0.003
  156. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20; 26(6):942-7.
    View in: PubMed
    Score: 0.003
  157. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008 Feb; 51(2):154-61.
    View in: PubMed
    Score: 0.003
  158. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007 Dec; 142(6):906-13; discussion 913.e1-2.
    View in: PubMed
    Score: 0.003
  159. Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors. Ann Thorac Surg. 2007 Nov; 84(5):1717-23.
    View in: PubMed
    Score: 0.003
  160. Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2007 Nov; 5(10):998-1033.
    View in: PubMed
    Score: 0.003
  161. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008 Feb; 206(2):247-54.
    View in: PubMed
    Score: 0.003
  162. Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol. 2007 Dec; 14(12):3321-7.
    View in: PubMed
    Score: 0.003
  163. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg. 2007 Nov; 11(11):1460-7; discussion 1467-9.
    View in: PubMed
    Score: 0.003
  164. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007 Sep; 246(3):375-81; discussion 381-4.
    View in: PubMed
    Score: 0.003
  165. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Anticancer Drugs. 2007 Jun; 18(5):535-41.
    View in: PubMed
    Score: 0.003
  166. Long-term treatment of plaque psoriasis with efalizumab: an Italian experience. Br J Dermatol. 2007 Apr; 156 Suppl 2:17-23.
    View in: PubMed
    Score: 0.002
  167. Early reexploration for excessive postoperative bleeding lowers wound complication rates in open heart surgery. Am Surg. 1987 Feb; 53(2):102-4.
    View in: PubMed
    Score: 0.002
  168. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007 Apr; 138(2):163-9.
    View in: PubMed
    Score: 0.002
  169. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer. 2006 Dec 29; 5:76.
    View in: PubMed
    Score: 0.002
  170. Mesothelial cyst of the pancreas. Ann Diagn Pathol. 2006 Dec; 10(6):371-3.
    View in: PubMed
    Score: 0.002
  171. On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells. Pancreas. 2006 Aug; 33(2):148-55.
    View in: PubMed
    Score: 0.002
  172. A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem Biophys Res Commun. 2006 Feb 24; 340(4):1224-8.
    View in: PubMed
    Score: 0.002
  173. LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem Biophys Res Commun. 2005 Sep 30; 335(3):949-56.
    View in: PubMed
    Score: 0.002
  174. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2005 Sep; 3(5):598-626.
    View in: PubMed
    Score: 0.002
  175. Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Cancer. 2005 Aug 05; 4:27.
    View in: PubMed
    Score: 0.002
  176. 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions. Cancer Res. 2005 Jul 15; 65(14):6011-6.
    View in: PubMed
    Score: 0.002
  177. A novel anti-pancreatic cancer agent, LY293111. Anticancer Drugs. 2005 Jun; 16(5):467-73.
    View in: PubMed
    Score: 0.002
  178. Identification and in silico characterization of a novel gene: TPA induced trans-membrane protein. Biochem Biophys Res Commun. 2005 Apr 08; 329(2):755-64.
    View in: PubMed
    Score: 0.002
  179. LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia. 2005 Apr; 7(4):417-25.
    View in: PubMed
    Score: 0.002
  180. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors. Mod Pathol. 2002 Dec; 15(12):1333-8.
    View in: PubMed
    Score: 0.002
  181. Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid. 2002 Dec; 12(12):1109-12.
    View in: PubMed
    Score: 0.002
  182. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001 Oct; 130(4):677-82; discussion 682-5.
    View in: PubMed
    Score: 0.002
  183. Molecular markers and prediction of response to chemoradiation in rectal cancer. Oncol Rep. 2001 May-Jun; 8(3):497-500.
    View in: PubMed
    Score: 0.002
  184. Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management. Surgery. 2000 Oct; 128(4):604-12.
    View in: PubMed
    Score: 0.002
  185. Esophageal leiomyomatosis in a woman with a history of vulvar leiomyoma and Barrett's esophagus: a case report and review of the literature. Dig Surg. 2000; 17(3):306-9.
    View in: PubMed
    Score: 0.002
  186. zo-2 gene alternative promoters in normal and neoplastic human pancreatic duct cells. Int J Cancer. 1999 Oct 29; 83(3):349-58.
    View in: PubMed
    Score: 0.001
  187. Results of gastric interposition for reconstruction of the pharyngoesophagus. Surgery. 1999 Oct; 126(4):666-71; discussion 671-2.
    View in: PubMed
    Score: 0.001
  188. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery. 1999 Oct; 126(4):714-20; discussion 720-2.
    View in: PubMed
    Score: 0.001
  189. Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma. Int J Cancer. 1999 Jul 02; 82(1):137-44.
    View in: PubMed
    Score: 0.001
  190. Society of Surgical Oncology: statement on genetic testing for cancer susceptibilty. Committee on Issues and Governmental Affairs of the Society of Surgical Oncology. Ann Surg Oncol. 1999 Jul-Aug; 6(5):507-9.
    View in: PubMed
    Score: 0.001
  191. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998 Apr 01; 82(7):1250-9.
    View in: PubMed
    Score: 0.001
  192. Atypical acinar cell foci in human pancreas. Morphological and morphometric analysis. Int J Pancreatol. 1997 Oct; 22(2):127-30.
    View in: PubMed
    Score: 0.001
  193. Gastric cancer. Radiologic staging. Radiol Clin North Am. 1997 Mar; 35(2):331-49.
    View in: PubMed
    Score: 0.001
  194. Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol. 1997 Jan; 64(1):74-8.
    View in: PubMed
    Score: 0.001
  195. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys. 1996 Jul 01; 35(4):745-9.
    View in: PubMed
    Score: 0.001
  196. Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol. 1996; 17(1):5-12.
    View in: PubMed
    Score: 0.001
  197. Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg. 1995 Oct; 130(10):1048-54.
    View in: PubMed
    Score: 0.001
  198. Expression of p68 in human colon cancer. Tumour Biol. 1995; 16(5):281-9.
    View in: PubMed
    Score: 0.001
  199. Site-specific differences in pp60c-src activity in human colorectal metastases. J Surg Res. 1993 Apr; 54(4):293-8.
    View in: PubMed
    Score: 0.001
  200. Sphincter-preserving extended resection for locally advanced rectosigmoid carcinoma involving the urinary bladder. J Surg Oncol. 1992 Jun; 50(2):77-80.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.